Arriello’s VP of Global Drug Safety Kieran O’Donnell and contributing consultant Nicola Kidman had the opportunity to speak at the BIO Europe Conference in Leipzig about the surprising results from our latest international survey.
Experienced experts and advisors to Arriello, Eric Caugant and Judi Sills highlight the main differences between US and EU Biotech safety requirements.
Arriello's COO Anna Lukyanova talks about how we apply the principles of faster, better, smarter to Pharmacovigilance at Arriello.
Some of the cookies used on this site and in our chatbot are essential, while others help us to improve your experience by providing insights into how the site is being used. Read more in our Cookie Notice and Privacy Policy.